Six FDI proposals receive govt approval
Published: Apr 25, 2017
By TIOLCORP News Service
NEW DELHI, APR 25, 2017: Based on the recommendations of the Foreign Investment Promotion Board (FIPB), the Government has approved six Foreign Direct Investment (FDI) proposals and recommended one proposal for the Cabinet Committee on Economic Affairs (CCEA).
The six proposals which have been approved are as follows:
S. No |
Name of the applicant |
Gist of the proposal |
Sector |
FDI (Rs. crore) |
1 |
M/s PMC Group International |
Approval has been sought for: (i) undertaking foreign investment upto 100%, through a newly incorporated Indian company M/s PMC YM-Pharma Private Limited and (ii) PMC YM-Pharma would purchase the manufacturing facility of an existing Indian pharmaceutical company Yegna Manojavam Drugs and Chemicals Limited. |
Pharma |
65.00 |
2 |
M/s Enaltec Labs Private Limited |
Post facto approval has been sought for issuance of CCPS to Medtech Limited, UAE in February 2012 and subsequent transfer of such CCPS by Medtech to Scitech Limited, UAE in March 2013. |
Pharma |
No fresh inflow |
3 |
M/s Powervision Export and Import India Private Limited |
M/s Powervision Export and Import India Private Limited has sought approval for foreign investment by a Bangladeshi citizen, which is an existing shareholder and director of the company. |
Whole sale Trading |
3.38 |
4 |
M/s Crown Cement Manufacturing India Pvt Ltd |
Approval has been sought for foreign investment from a Bangladeshi entity, M/s M.I. Cement. |
Manufacturing |
15.51 |
5 |
M/s Bigtec Pvt. Ltd (Bigtec) |
Bigtec, an Indian Company, has sought post facto approval for swap of shares to its holding Company, M/s Bigtec Innovations Private Limited (BIPL), also an Indian Company, in the fair exchange ratio (for every 1 share of Bigtec, 2 shares of BIPL was allotted). |
Pharma |
Nil |
6 |
M/s Entrepreneur India Media Private Limited |
Approval has been sought for undertaking the additional business of publishing scientific and technical magazines |
Publishing |
0.80 |
The following proposal has been recommended for CCEA approval:
S. No |
Name of the applicant |
Gist of the proposal |
Sector |
FDI (Rs. crore) |
1 |
M/s Gland Pharma Limited |
M/s Gland Pharma Limited, a brownfield pharmaceutical Indian company, is seeking approval for its initial acquisition of up to 86.08% by M/s Shanghai Fosun Pharmaceutical (Group) Company Limited, a public listed company incorporated in China through its subsidiaries outside India namely M/s Fosun Pharma Industrial Pte. Ltd. , M/s Fosun Industrial Co Limited, Ample Up Limited, M/s Lustrous Star Limited and M/s Regal Gesture Limited and subsequently, Fosun also has the contractual right to acquire 100% shares of Gland Pharma from the other shareholders of the Company in one or more tranches. |
Pharma |
4,315.00 |
However, the proposals of the following companies have been deferred:
1. Geodis Overseas Pvt. Ltd
2. Sistema Shyam TeleServices Limited
3. Hindustan Ports Private Limited
4. Datawind Innovations Private Limited
5. Vodafone Mobile Services Limited
6. HSBC Securities and Capital Markets (India) Private Limited
7. Ubiquity SRL
8. Ghel Rendev India Private Limited
9. G4S Secure Solutions (India) Private Limited
10. Celon Laboratories Limited
The proposals belonging to the 5 companies have been rejected namely - PERI India Pvt. Ltd, Limpkin Telecom Private Limited, LS Cable India Private Limited, Maxaim Network Private Limited and Xerox India Limited.